Sean Moloughney, Editor10.01.15
As an ingredient segment, the omega-3 market has long been a shining star of the nutraceuticals industry. Supported by a large school of clinical data regarding the safety and efficacy of EPA and DHA for heart health, brain development, and a host of other vital areas of wellness, omega-3 sales have seen significant growth, gaining favor among healthcare professionals and consumers.
However, a mature omega-3 market has encountered significant challenges in recent years. For example, some highly publicized studies failed to demonstrate previously reported health benefits, but succeeded in getting significant mainstream media coverage. As a result, sales have dipped, compelling a coalition of companies under the guidance of the Global Organization for EPA and DHA Omega-3s (GOED), Salt Lake City, UT, to launch a public relations campaign focused on correcting the record and communicating positive news.
Challenges & Solutions
Despite some sizeable challenges, experts remain positive about the long-term future of the market. “After three decades of strong growth, t
However, a mature omega-3 market has encountered significant challenges in recent years. For example, some highly publicized studies failed to demonstrate previously reported health benefits, but succeeded in getting significant mainstream media coverage. As a result, sales have dipped, compelling a coalition of companies under the guidance of the Global Organization for EPA and DHA Omega-3s (GOED), Salt Lake City, UT, to launch a public relations campaign focused on correcting the record and communicating positive news.
Challenges & Solutions
Despite some sizeable challenges, experts remain positive about the long-term future of the market. “After three decades of strong growth, t
Continue reading this story and get 24/7 access to Nutraceuticals World for FREE
FREE SUBSCRIPTION
